Literature DB >> 30811894

OPTN/SRTR 2017 Annual Data Report: Heart.

M Colvin1,2, J M Smith1,3, N Hadley1, M A Skeans1, K Uccellini4,5, R Lehman4,5, A M Robinson4,5, A K Israni1,6,7, J J Snyder1,6, B L Kasiske1,7.   

Abstract

In 2017, 3273 heart transplants were performed in the United States. New listings continued to increase, and 3769 new adults were listed for heart transplant in 2017. Over the past decade, posttransplant mortality has declined. The number of new pediatric listings increased over the past decade, as did the number of pediatric heart transplants, although some fluctuation has occurred more recently. New listings for pediatric heart transplants increased from 481 in 2007 to 623 in 2017. The number of pediatric heart transplants performed each year increased from 330 in 2007 to 432 in 2017, slightly fewer than in 2016. Short-term and long-term mortality improved. Among pediatric patients who underwent transplant between 2015-2016, 4.8% had died by 6 months and 6.2% by 1 year. .

Entities:  

Keywords:  End-stage heart failure; heart transplant; transplant outcomes; ventricular assist device

Mesh:

Year:  2019        PMID: 30811894     DOI: 10.1111/ajt.15278

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  35 in total

1.  Practice Changes at U.S. Transplant Centers After the New Adult Heart Allocation Policy.

Authors:  William F Parker; Kevin Chung; Allen S Anderson; Mark Siegler; Elbert S Huang; Matthew M Churpek
Journal:  J Am Coll Cardiol       Date:  2020-06-16       Impact factor: 24.094

Review 2.  Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine.

Authors:  Martha E Floy; Taylor D Mateyka; Koji L Foreman; Sean P Palecek
Journal:  Stem Cell Res       Date:  2020-04-27       Impact factor: 2.020

3.  Pediatric heart transplantation: advancing the field into the future.

Authors:  Justin Godown; Shawn C West
Journal:  Transl Pediatr       Date:  2019-10

4.  Expanding the pool: the use of hepatitis C RNA positive organs in lung transplantation.

Authors:  Ernest G Chan; Patrick G Chan; Pablo G Sanchez
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

5.  Impact of Deceased Donor Management on Donor Heart Use and Recipient Graft Survival.

Authors:  Elizabeth A Swanson; Tony Adams; Madhukar S Patel; Salvador De La Cruz; Michael Hutchens; Kiran Khush; Mitchell B Sally; Claus U Niemann; Tahnee Groat; Darren J Malinoski
Journal:  J Am Coll Surg       Date:  2020-06-17       Impact factor: 6.113

6.  Validating patient prioritization in the 2018 Revised United Network for Organ Sharing Heart Allocation System: A single-center experience.

Authors:  Aditi Nayak; Tiffany Dong; Yi-An Ko; Neile Chesnut; Ann Pekarek; Robert T Cole; Kunal Bhatt; Divya Gupta; Michael A Burke; S Raja Laskar; Tamer Attia; Andrew L Smith; J David Vega; Alanna A Morris
Journal:  Clin Transplant       Date:  2020-02-28       Impact factor: 2.863

7.  Association of Gender and Race With Allocation of Advanced Heart Failure Therapies.

Authors:  Khadijah Breathett; Erika Yee; Natalie Pool; Megan Hebdon; Janice D Crist; Ryan H Yee; Shannon M Knapp; Sade Solola; Luis Luy; Kathryn Herrera-Theut; Leanne Zabala; Jeff Stone; Marylyn M McEwen; Elizabeth Calhoun; Nancy K Sweitzer
Journal:  JAMA Netw Open       Date:  2020-07-01

8.  Great variability in donor heart acceptance practices across the United States.

Authors:  Kiran K Khush; Robyn L Ball
Journal:  Am J Transplant       Date:  2020-01-20       Impact factor: 8.086

Review 9.  Current Role of the Total Artificial Heart in the Management of Advanced Heart Failure.

Authors:  Nathaniel Melton; Behzad Soleimani; Robert Dowling
Journal:  Curr Cardiol Rep       Date:  2019-11-22       Impact factor: 2.931

10.  Heart Transplantation: An In-Depth Survival Analysis.

Authors:  Eileen M Hsich; Eugene H Blackstone; Lucy W Thuita; Dennis M McNamara; Joseph G Rogers; Clyde W Yancy; Lee R Goldberg; Maryam Valapour; Gang Xu; Hemant Ishwaran
Journal:  JACC Heart Fail       Date:  2020-06-10       Impact factor: 12.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.